Articles dans des revues avec comité de lecture (367)

  1. 22. Dubois, N., Crompot, E., Meuleman, N., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2020). Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles. Frontiers in oncology, 10, 1422. doi:10.3389/fonc.2020.01422
  2. 23. Buyl, K., Merimi, M., Rodrigues, R. M., Moussa Agha, D., Melki, R., Vanhaecke, T., Bron, D., Lewalle, P., Meuleman, N., Fahmi, H., Rogiers, V., Lagneaux, L., Kock, J. D., & Najar, M. (2020). The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells. Journal of Clinical Medicine, 9(3), 696. doi:10.3390/jcm9030696
  3. 24. Roex, G., Feys, T., Beguin, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2020). Chimeric antigen receptor-T-cell therapy for B-cell hematological malignancies: An update of the pivotal clinical trial data. Pharmaceutics, 12(2), 194. doi:10.3390/pharmaceutics12020194
  4. 25. Devos, T., Verhoef, G. E. G., Steel, E., Mazure, D., Lewalle, P., Bron, D., Berneman, Z. N., Benghiat, F., Mineur, P., Theunissen, K., Zachée, P., Doyen, C., Put, N., Lejeune, M., Van Eygen, K., Havelange, V., Reusens, M., Pluymers, W., & Peeters, K. (2019). Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium. Acta haematologica. doi:10.1159/000499329
  5. 26. Porcu, M., De Silva, P., Solinas, C., Battaglia, A., Schena, M., Scartozzi, M., Bron, D., Suri, J. J., Willard-Gallo, K., Sangiolo, D., & Saba, L. (2019). Immunotherapy associated pulmonary toxicity: Biology behind clinical and radiological features. Cancers (Basel), 11(3), 305. doi:10.3390/cancers11030305
  6. 27. Najar, M., Fayyad Kazan, M., Merimi, M., Meuleman, N., Bron, D., Fayyad Kazan, H., & Lagneaux, L. (2019). Reciprocal immuno-biological alterations occur during the co-culture of natural killer cells and adipose tissue-derived mesenchymal stromal cells. Cytotechnology, 71(1), 375-388. doi:10.1007/s10616-019-00294-6
  7. 28. Solinas, C., De Silva, P., Bron, D., Willard-Gallo, K., & Sangiolo, D. (2019). Significance of TIM3 expression in cancer: From biology to the clinic. Seminars in oncology. doi:10.1053/j.seminoncol.2019.08.005
  8. 29. Rouas, R., Merimi, M., Najar, M., Zein, N. E., Fayyad Kazan, M., Berehab, M., Moussa Agha, D., Bron, D., Burny, A., Rachidi, W., Badran, B., Lewalle, P., & Fayyad Kazan, H. (2019). Human CD8+ CD25 + CD127 low regulatory T cells: microRNA signature and impact on TGF-β and IL-10 expression. Journal of cellular physiology, 234(10), 17459-17472. doi:10.1002/jcp.28367
  9. 30. Gagelmann, N., Eikema, D. J., Koster, L., Caillot, D., Pioltelli, P., Lleonart, J. B., Reményi, P., Blaise, D., Schaap, N., Trneny, M., Passweg, J., Porras, R. P., Cahn, J.-Y., Musso, M., Poiré, X., Fenk, R., Itälä-Remes, M., Pavone, V., Fouillard, L., Maertens, J. A., Bron, D., Pouli, A., Schroyens, W., Schönland, S., Garderet, L., Yakoub-Agha, I., & Kröger, N. (2019). Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Biology of blood and marrow transplantation. doi:10.1016/j.bbmt.2019.07.004
  10. 31. Thieblemont, C., Howlett, S., Casasnovas, R. O., Mounier, N., Perrot, A., Morschhauser, F., Fruchart, C., Daguindau, N., Van Eygen, K., Obéric, L., Bouabdallah, R., Pica, G. M., Nicolas-Virezelier, E., Abraham, J., Fitoussi, O., Snauwaert, S., Eisenmann, J. C., Lionne-Huyghe, P., Bron, D., Tricot, S., Deeren, D., Gonzalez, H., Costello, R., Le Du, K., Da Silva, M. G., Grosicki, S., Trotman, J., Catalano, J., Caballero, D., Greil, R., Cohen, A. A., Gaulard, P., Roulin, L., Takeshita, K., Casadebaig, M. L., Tilly, H., & Coiffier, B. (2019). Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study. British journal of haematology. doi:10.1111/bjh.16300
  11. 32. Chi, V. L. D., Garaud, S., De Silva, P., Thibaud, V., Stamatopoulos, B., Berehad, M., Gu-Trantien, C., Krayem, M., Duvillier, H., Lodewyckx, J. N., Willard-Gallo, K., Sibille, C., & Bron, D. (2019). Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC cancer, 19(1), 81. doi:10.1186/s12885-019-5276-2
  12. 33. Najar, M., Fayyad Kazan, M., Merimi, M., Burny, A., Bron, D., Fayyad Kazan, H., Meuleman, N., & Lagneaux, L. (2018). Mesenchymal stromal cells and natural killer cells: a complex story of love and hate. Current Stem Cell Research & Therapy. doi:10.2174/1574888X13666180912125736

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 Suivant >>